title: Should patients with central core disease be screened for malignant hyperthermia?
authors.forename: P J
authors.initials: PJ
authors.lastname: Halsall
authors.forename: L R
authors.initials: LR
authors.lastname: Bridges
authors.forename: F R
authors.initials: FR
authors.lastname: Ellis
authors.forename: P M
authors.initials: PM
authors.lastname: Hopkins
mesh_terms: D000328:Adult; D002888:Chromosomes, Human, Pair 19; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008305:Malignant Hyperthermia / Q000150:complications* / Q000175:diagnosis*; D009119:Muscle Contraction; D017696:Myopathies, Nemaline / Q000150:complications* / Q000175:diagnosis / Q000235:genetics; D017354:Point Mutation; D012720:Severity of Illness Index